When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue ...

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery.

India has had a predictable policy regime under Mr. Modi’s leadership, which supports investment and deal activity, and it ...

Ovarian Cancer Drugs Market grows as FDA, EMA fast-track advanced-stage therapies, boosting global approvals and innovation. Anurag Tiwari Orion Market Research Pvt Ltd + +91 91798 28694 email us here ...

Motilal Oswal Financial Services recommends Suzlon and Glenmark Pharma as top stock picks for the week starting July 14, 2025. Suzlon anticipates healthy order inflows, potentially reaching 6.5GW by ...

Analysts say that the banking giant faces headwinds from declining net interest income due to lower rates and increased ...

One of the biggest reasons to buy DIVO instead of SCHD is because it is actively managed. This active management attempts to ...

President Trump is pushing through with his tariff agenda, unveiling a new batch of letters to country leaders outlining ...

Global active pharmaceutical ingredients (API) market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, ...

North America active pharmaceutical ingredients (API) market is projected to grow by 4.8% annually in the forecast period and reach $120.7 billion by 2032, driven by rising adoption of biologics in ...

Everything to Know about Macro and Markets Stock indexes fell on Friday, reversing mid‑week gains and closing in the red, as the tariff theme came ...

Penserra Capital Management significantly reduced its stake in Vertex Pharmaceuticals, dropping 81% of its shares in the ...